ICyte Platform: Pharma Market Access Software

Commercial Benefits of Using Market Access Data in Pharma

With ICyte, pharmaceutical and biotech organizations improve market access by quickly transforming patient, payer, complex transaction, and channel data into actionable insights. Contract & Pricing teams can manage regulatory processes, risks, delays, compliance issues and revenue leakage.

Commercial and market access leaders can align on optimal channel design, using syndicated data to capture how the product is distributed to points of care. Our pharma market access software provides:

• Data driven analytics and transaction level data shared during coaching sessions with SPs help resolve these challenges
• Market leading patient matching approach of leveraging configurable probabilistic matching, third-party reference data through Verato, and use of contextual information accomplish better patient matching.
• Differentiated data quality management approach, cross-functional team, and system platform can enable the following use cases:
  • Line-level rebate adjudication for specialty medicines 
  • Adjudication of adherence-based (value-based) payer contracts 
  • Pre-deal modeling of potential new payer and provider contracting strategies 
  • Filling in data gaps in the gross-to-net accrual management process

Financial Benefits of Pharma Market Access Software

Optimizing the net revenue-patient access equation is top-of-mind to all financial executives, regardless of the size or complexity of their company.

The key to achieving an accurate, transparent, and audit-ready gross-to-net (GTN) forecast is to have reliable, trusted inputs that cover all facets of commercialization including:

• Rebates
• Discounts
• Co-pay Programs
• Chargebacks
• Admin Fees
• And other sales-related adjustments

For most pharmaceutical organizations, this data exists in different systems, in different formats, and with different degrees of access. The ICyte Platform changes all of this. By building a commercialization strategy on market access software, all of the required GTN inputs are stored, mastered, and curated in a common manner on the same platform.

Operational Benefits of the ICyte Platform

Pharmaceutical companies that use ICyte for their market access needs see a wealth of operational benefits including:

• Hassle-free Integration with their existing infrastructure including current data sets as well as revenue management, CRM, ERP, Data Warehouse, and Enterprise BI applications.
• Seamless Interoperability with IntegriChain Products regardless of when they’re purchased, and provide a standard way to publish data to enterprise/commercial data warehouses.
• Investment Protection specifically designed to service market access functions. It co-exists with existing IT investments and infrastructure across CRM, ERP, data warehouse, and analytics systems.
• Reduced Risk built with inherent security and scalability considerations. It is SOC 2 compliant and is hosted on AWS, leveraging proven and modern technology foundations to serve customers. All access to data is through secure protocols and encrypted in our services with the latest standards.
• Maximize Value in order for pharmaceutical organizations to realize lower costs due to reduced vendor mix, less contracting complexity, and elimination of duplicate services.